Navigation Links
Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Date:8/19/2007

ng the first six months of 2007, net cash used in operating activities was $16.8 million.

Conference Call and Webcast

Genta management will host a conference call and live audio webcast to discuss financial results and general corporate activities on August 7, 2007 at 8:00 am EDT.

Conference call information:

US/Canada call: 877-634-8606; conference code Genta Incorporated

International call: 706-679-3140; conference code Genta Incorporated

Webcast: http://www.genta.com/genta/InvestorRelation/events.html

The webcast will be archived for 30 days. Audio replay will be available approximately two hours after completion of the call, and will be archived for 30 days. Access numbers for this replay are: (800) 642-1687 (U.S./Canada) and (706) 645-9291 (International); conference ID number is 11209530.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named- patient" basis in countries outside the United States. For more information about Genta, please visit our website at:

SOURCE Genta Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LOUISVILLE, Ky. , Sept. 18, 2014 ... of innovative laboratory technologies and products to ... settings, announced today an amended distributorship agreement ... Sysmex reagents, controls and instruments, including the ... , Sysmex XP-300™, XT-Series and XN-Series Automated ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "Micro Market Monitor : Global Chiral Separation Columns Market" ... separation chromatography is a technique involving two enantiomers of ... phase consisting of a single enantiomer, thus possessing different ... oligosaccharides such as cellulose. The chiral separation ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... PTCA Balloon Market Investment Report, 2014-2016" report to ... indispensable medical device in percutaneous coronary intervention (PCI), serves ... also as a device for pre-/post-stent dilatations. Therefore, the ... that of PCI. As national economy develops ...
Breaking Medicine Technology:LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3Micro Market Monitor: Global Chiral Separation Columns Market 2China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3
... Sept. 22 Today, Advanced Health Media, LLC ... Leonard as Chief Compliance Officer. Ms. Leonard will ... communicating regulatory governance associated with the pharmaceutical, biotechnology ... regulatory experience in our industry will further strengthen ...
... Molecular Detection Inc. (MDI), a company developing Detect-Ready™ ... of infectious disease diagnosis, and Integrated Sciences Pty. ... an exclusive distribution agreement for MDI,s Detect-Ready MRSA ... healthcare providers a high-performance MRSA screening test with ...
Cached Medicine Technology:Advanced Health Media Further Expands Investment in Regulatory Compliance; Company Announces Ms. Susan Y. Leonard as Chief Compliance Officer 2Molecular Detection and Integrated Sciences Announce Distribution Agreement for Detect-Ready™ MRSA Assay in Australia 2Molecular Detection and Integrated Sciences Announce Distribution Agreement for Detect-Ready™ MRSA Assay in Australia 3Molecular Detection and Integrated Sciences Announce Distribution Agreement for Detect-Ready™ MRSA Assay in Australia 4
(Date:9/18/2014)... September 19, 2014 In ... Neighborhood Mission (Misión Barrio Adentro), which it ... healthcare system (see Section 6.1.3.). In 2009, ... an Autonomous Service of Pharmaceutical Elaborations (Servicio ... which provides medicines at a cheaper rate ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Thousands of ... be recognizing their shared fundraising impact on 127 member ... 25. , The first-ever Dance Marathon Day will officially ... million projected to be raised by college and high ... Hospital. Donations generated through Dance Marathon campus programs help ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Ben Quirk, ... Alex Ormond, Jr. Leadership Award by the Savannah Science ... healthcare and wellness throughout the nation and especially in ... this award,” said Ben. “The Savannah Science Seminar is ... years and multiple generations have gone through the program,” ...
(Date:9/18/2014)... don,t worry, it,s a good thing! As scientists have ... bad. Many active enzymes and bacteria are merely benign, ... important part of our digestive system or can help ... an opportunistic yeast pathogen and model organism for research, ... ecosystem. However, when our immune system is stressed on ...
(Date:9/18/2014)... Non-governmental stakeholders will convene a one-day conference at the ... Washington University on September 25, 2014 to discuss the ... GHSA implementation. The purpose of this event is to ... the next five years, including action plans to curtail ... launch of the GHSA, international organizations and more than ...
Breaking Medicine News(10 mins):Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 3Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2
... HealthDay Reporter , MONDAY, Sept. 20 (HealthDay News) -- ... be traced to a unexpected cause -- a certain strain ... research shows that youngsters who were infected by adenovirus 36, ... an average of 50 pounds heavier than children who hadn,t ...
... of Law at Arizona State University has been named ... Network, which launches today to provide legal and policy ... such as food safety, health reform and emergency preparedness. ... (PHLPP) received a $1.325 million grant from the Robert ...
... prostate tumors, promotes the growth of a different type of ... on September 20 in the Journal of Experimental Medicine ... colleagues find that TAL1, a protein abundantly expressed in approximately ... drives expression of NKX3.1. Eliminating NKX3.1 halted the growth ...
... FASEB MARC (Minority Access to Research Careers) Program ... Integrative Physiology of Exercise (IPE) Meeting in Miami, Florida ... meant to promote the entry of underrepresented minority students, ... science community and to encourage the participation of young ...
... Reporter , SUNDAY, Sept. 19 (HealthDay News) -- For asthma ... the addition of Spiriva -- a medication already approved for ... finds. However, the study authors and an outside expert ... clinical trials are needed. Tiotropium bromide (Spiriva)) belongs to ...
... of cancer researchers has identified four chromosome locations with ... risk of developing ovarian cancer. The findings appear in ... a Mayo Clinic researcher. Researchers say that while ... the specific chromosomal regions involved in susceptibility, the discoveries ...
Cached Medicine News:Health News:Childhood Obesity Might Be Linked to Strain of Cold Virus 2Health News:Childhood Obesity Might Be Linked to Strain of Cold Virus 3Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 2Health News:11-state regional Public Health Law Network office to be established at ASU College of Law 3Health News:Early Trial Suggests COPD Drug Might Help Some Asthmatics 2Health News:Early Trial Suggests COPD Drug Might Help Some Asthmatics 3
... and international engineering and design specifications, ... Plating System* provides seamless integration with ... for open reduction internal fixational procedures ... works well beyond the standard, providing ...
... represents one of the most technically demanding ... Plating System offers the highly specialized surgeon ... fractures of the pelvis and acetabulum. ... a premiere pelvic surgeon, is the designer ...
... Conforming to U.S. and international engineering ... TC-100 Screw and Plating System* provides ... ease of use for open reduction ... the TC-100 system works well beyond ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: